Additional information
| Active substance | Arimistane | 
|---|---|
| Active Half-Life | 2-4 hours | 
| Classification | Aromatase Inhibitor | 
| Dosage | 50 mg/day | 
| Acne | No | 
| Water Retention | No | 
| HBR | No | 
| Hepatotoxicity | No | 
| Aromatization | No | 
| Lab Test | See Document | 
| Also known as | Arimistane | 
| WAREHOUSE | USA Warehouse 2 | 
| Blood pressure | Can potentially increase if water retention occurs | 
| Trade name | Not commercially available as a medication | 
| Storage conditions | Store in a cool, dry place away from light | 
| Chemical name | Androsta-3,5-diene-7,17-dione | 
| Formula | C19H24O2 | 
| Substance class | Steroidal aromatase inhibitor | 
| Main action | Inhibition of aromatase enzyme, reducing estrogen synthesis | 
| Half-life | 48 hours | 
| Dosage (medical) | Not typically used for medical purposes | 
| Dosage (sports) | 50-75 mg per day | 
| Effects | Increased testosterone levels, decreased estrogen levels | 
| Side effects | Potential hormonal imbalances, risk of joint discomfort, and potential impact on lipid profiles | 
| Use in sports | Used as an ancillary compound to manage estrogen levels in anabolic steroid cycles | 
| Manufacturer | Spectre Labs | 
 Arimidex Aaster Health and Sports Solutions
							Arimidex Aaster Health and Sports Solutions						

 
			 
			 
			 
			
Reviews
There are no reviews yet.